CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations....
Phase 3
La Jolla, California, United States and 210 other locations
Lung cancer is the leading cause of cancer deaths. Advances in the systemic treatment of non-small cell lung cancer...
Phase 2
La Jolla, California, United States of America
This study is designed to evaluate the antitumor activity of patritumab deruxtecan in participants with metastatic or locally advanced NSCLC with an...
Phase 2
La Jolla, California, United States and 124 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
La Jolla, California, United States and 52 other locations
This study was designed to evaluate safety and antitumor activity of HER3-DXd in two parts: Dose Escalation and Dose Expansion.In Dose Escalation, HE...
Phase 1
La Jolla, California, United States and 36 other locations
type of side effects may occur with the drug treatment. It will also measure the levels of drug in the body and preliminarily assess its anti-cancer...
Phase 1, Phase 2
La Jolla, California, United States and 124 other locations
purpose of this study is to evaluate how well Rina-S works against lung cancer.The treatment in this study is Rina-S monotherapy (b...
Phase 2
San Diego, California, United States and 73 other locations
Non-small cell lung cancer (NSCLC) is a common type of lung cancer where abnormal cells in the lungs gro...
Phase 2, Phase 3
La Jolla, California, United States and 115 other locations
The purpose of this platform study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of novel RAS(ON...
Phase 1, Phase 2
San Diego, California, United States and 93 other locations
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival ...
Phase 2, Phase 3
La Jolla, California, United States and 61 other locations
Clinical trials
Research sites
Resources
Legal